论文信息 - Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeae. - 字舞流文

Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeae.

R. Jones | M. Erwin | M. Barrett

[1] R. N. Brogden,et al. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. , 1992, Drugs.

[2] A. Barry,et al. Interpretive criteria for antimicrobial susceptibility tests with cefodizime discs. , 1991, The Journal of antimicrobial chemotherapy.

[3] M. Labro. Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties. , 1990, The Journal of antimicrobial chemotherapy.

[4] J. Knapp,et al. Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea , 1988, Antimicrobial Agents and Chemotherapy.

[5] M. Schäfer-Korting,et al. Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers , 1987, Antimicrobial Agents and Chemotherapy.

[6] R. Jones,et al. In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin , 1981, Antimicrobial Agents and Chemotherapy.